申请人:Ionis Pharmaceuticals, Inc.
公开号:US11312964B2
公开(公告)日:2022-04-26
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with excess growth hormone using antisense compounds or oligonucleotides targeted to growth hormone receptor (GHR).
本发明的实施方案提供了利用针对生长激素受体(GHR)的反义化合物或寡核苷酸治疗、预防或改善与过量生长激素有关的疾病的方法、化合物和组合物。